U.S. flag

An official website of the United States government

NM_000334.4(SCN4A):c.4307T>C (p.Leu1436Pro) AND Familial hyperkalemic periodic paralysis

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 4, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000819512.11

Allele description [Variation Report for NM_000334.4(SCN4A):c.4307T>C (p.Leu1436Pro)]

NM_000334.4(SCN4A):c.4307T>C (p.Leu1436Pro)

Genes:
GH-LCR:growth hormone locus control region [Gene]
SCN4A:sodium voltage-gated channel alpha subunit 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q23.3
Genomic location:
Preferred name:
NM_000334.4(SCN4A):c.4307T>C (p.Leu1436Pro)
HGVS:
  • NC_000017.11:g.63941975A>G
  • NG_011699.1:g.35944T>C
  • NG_042788.1:g.24883A>G
  • NM_000334.4:c.4307T>CMANE SELECT
  • NP_000325.4:p.Leu1436Pro
  • NC_000017.10:g.62019335A>G
Protein change:
L1436P
Links:
dbSNP: rs1598405334
NCBI 1000 Genomes Browser:
rs1598405334
Molecular consequence:
  • NM_000334.4:c.4307T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hyperkalemic periodic paralysis
Synonyms:
Hyperkalemic periodic paralysis; Gamstorp episodic adynamy; Gamstorp disease
Identifiers:
MONDO: MONDO:0008224; MedGen: C0238357; Orphanet: 682; OMIM: 170500; Human Phenotype Ontology: HP:0007215

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000960177Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jun 4, 2021)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed.

Matthews E, Tan SV, Fialho D, Sweeney MG, Sud R, Haworth A, Stanley E, Cea G, Davis MB, Hanna MG.

Neurology. 2008 Jan 1;70(1):50-3. doi: 10.1212/01.wnl.0000287069.21162.94.

PubMed [citation]
PMID:
18166706

Prevalence study of genetically defined skeletal muscle channelopathies in England.

Horga A, Raja Rayan DL, Matthews E, Sud R, Fialho D, Durran SC, Burge JA, Portaro S, Davis MB, Haworth A, Hanna MG.

Neurology. 2013 Apr 16;80(16):1472-5. doi: 10.1212/WNL.0b013e31828cf8d0. Epub 2013 Mar 20.

PubMed [citation]
PMID:
23516313
PMCID:
PMC3662361
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000960177.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed to segregate with autosomal dominant paramyotonia congenita in several families (PMID: 18166706, 23516313, 26036855, 21664816). This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with proline at codon 1436 of the SCN4A protein (p.Leu1436Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024